|
Issue |
Title |
|
Vol 21, No 1 (2025) |
Clinical case of locally advanced renal cell carcinoma with an inferior vena cava tumor thrombus treated with VEGFR-TKI/IO combination pembrolizumab + lenvatinib |
Abstract
PDF (Rus)
|
R. V. Orlova, M. I. Shkolnik, M. I. Gluzman, O. A. Bogomolov, A. V. Kozlov, S. A. Sidorova, I. O. Rutkin |
|
Vol 20, No 3 (2024) |
Metastasectomy in patients with multiple and oligometastases of renal cell carcinoma treated in general clinical practice |
Abstract
PDF (Rus)
|
D. V. Semenov, R. V. Orlova, V. I. Shirokorad, S. V. Kostritskiy, N. A. Karlova |
|
Vol 20, No 3 (2024) |
Functional results of partial nephrectomy depending on the use of various intraoperative techniques |
Abstract
PDF (Rus)
|
A. A. Seregin, A. V. Seregin, A. E. Dadasheva, M. A. Ibragimov, N. S. Mulabaev, K. B. Kolontarev, O. B. Loran |
|
Vol 20, No 3 (2024) |
Efficacy of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell carcinoma |
Abstract
PDF (Rus)
|
M. I. Volkova, A. S. Kalpinskiy, О. A. Goncharova, К. V. Menshikov, O. A. Stativko, E. V. Karabina, A. S. Dergunov, N. I. Polshina, E. N. Aleksandrova, A. A. Lebedinets, A. K. Panov, A. V. Sultanbaev, E. A. Usynin, M. V. Volkonsky, V. V. Mikhalyuk, R. A. Zukov, Yu. V. Anzhiganova, M. A. Gusniev, E. N. Igumnova, S. V. Kuzmicheva, I. A. Pokataev, A. S. Olshanskaya, N. I. Pervakova, E. L. Parsadanova, T. A. Sannikova, A. A. Bystrov, D. M. Dubovichenko, M. R. Mukhitova, V. A. Chubenko, K. A. Shkret, M. N. Gorshenina, A. V. Semenov, M. K. Davlatova, A. E. Kosareva, O. A. Lutoshkina, O. A. Maslova, M. V. Makhnutina, A. V. Mishina, M. Zh. Murzalina, O. A. Podyacheva, S. A. Kalinin, O. A. Mailyan, A. R. Safarova, K. O. Semenova, M. A. Strokova, E. Yu. Urashkina, O. S. Shmygina, O. Yu. Novikova |
|
Vol 20, No 2 (2024) |
Effectiveness of modern immunotherapy in combination treatment of patients with renal cancer and bone metastases |
Abstract
PDF (Rus)
|
S. V. Kostritskiy, V. I. Shirokorad, D. V. Semenov, A. S. Kalpinskiy, P. V. Kononets |
|
Vol 20, No 2 (2024) |
Lenvatinib and pembrolizumab combination in metastatic renal cell carcinoma: experience of the Republic of Bashkortostan |
Abstract
PDF (Rus)
|
K. V. Menshikov, D. O. Lipatov, A. F. Nasretdinov, Sh. I. Musin, N. I. Sultanbaeva, I. A. Menshikova, A. V. Sultanbaev, A. A. Izmaylov, Sh. N. Galimov, A. Sh. Rezyapova |
|
Vol 20, No 1 (2024) |
Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms |
Abstract
PDF (Rus)
|
V. Grünwald, T. Powles, M. Eto, E. Kopyltsov, S. Y. Rha, C. Porta, R. Motzer, T. E. Hutson, M. J. Méndez-Vidal, S. H. Hong, E. Winquist, J. C. Goh, P. Maroto, T. Buchler, T. Takagi, J. E. Burgents, R. Perini, C. He, C. E. Okpara, J. McKenzie, T. K. Choueiri |
|
Vol 20, No 1 (2024) |
Nephrometry scoring systems RENAL, PADUA, C-index, SPARE, and ZONAL NePhRO for prediction of partial nephrectomy outcomes |
Abstract
PDF (Rus)
|
B. G. Guliev, I. A. Povago |
|
Vol 19, No 4 (2023) |
First experience of using Pembroria® medication in patients with disseminated renal cell carcinoma |
Abstract
PDF (Rus)
|
I. M. Shevchuk, N. D. Movchan |
|
Vol 19, No 4 (2023) |
Survival by depth of response and efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma: analysis of the phase 3 randomized CLEAR study |
Abstract
PDF (Rus)
|
V. Grünwald, T. Powles, E. Kopyltsov, V. Kozlov, T. Alonso-Gordoa, M. Eto, T. Hutson, R. Motzer, E. Winquist, P. Maroto, B. Keam, G. Procopio, S. Wong, B. Melichar, F. Rolland, M. Oya, K. Rodriguez-Lopez, K. Saito, J. McKenzie, C. Porta |
|
Vol 19, No 4 (2023) |
Functional outcomes of repeat kidney resection in patients with cancer recurrence after nephron-sparing surgeries |
Abstract
PDF (Rus)
|
N. K. Zhumabaev, M. I. Komarov, A. V. Klimov, V. B. Matveev, I. S. Stilidi |
|
Vol 19, No 4 (2023) |
Metastasis suppressor kisspeptin (KISS1) in serum of patients with renal cell carcinoma |
Abstract
PDF (Rus)
|
N. E. Kushlinskii, O. V. Kovaleva, E. S. Gershtein, A. A. Alferov, Yu. B. Kuzmin, S. D. Bezhanova, I. A. Klimanov, N. V. Lyubimova, A. N. Gratchev, N. N. Zybina, V. B. Matveev, I. S. Stilidi |
|
Vol 19, No 3 (2023) |
Acute kidney injury and its predictors in surgery of malignant kidney tumors |
Abstract
PDF (Rus)
|
K. V. Pozdnyakov, S. A. Rakul, R. A. Eloev, K. A. Lukinov |
|
Vol 19, No 3 (2023) |
Cytoreductive nephrectomy and its effect on prognosis in patients with disseminated renal cell carcinoma receiving treatment in wide clinical practice |
Abstract
PDF (Rus)
|
D. V. Semenov, R. V. Orlova, V. I. Shirokorad, S. V. Kostritskiy, M. I. Gluzman, Yu. S. Korneva |
|
Vol 19, No 3 (2023) |
Review of the article “Acute kidney injury and its predictors in surgery of malignant kidney tumors” |
Abstract
PDF (Rus)
|
D. V. Perlin |
|
Vol 19, No 2 (2023) |
Characterization and management of adverse reactions from the CLEAR study in advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab |
Abstract
PDF (Rus)
|
R. Motzer, S. George, J. R. Merchan, T. E. Hutson, X. Song, R. F. Perini, R. Xie, U. Bapat, J. Puente |
|
Vol 19, No 2 (2023) |
Correlation between 3D morphometric characteristics of kidney tumors and their histological structure |
Abstract
PDF (Rus)
|
D. N. Fiev, E. S. Sirota, V. V. Kozlov, A. V. Proskura, E. V. Shpot, M. M. Chernenkiy, I. M. Chernenkiy, K. B. Puzakov, K. R. Azil’gareeva, Kh. M. Ismailov, D. V. Butnaru, A. Kutikov, A. Z. Vinarov |
|
Vol 19, No 1 (2023) |
The role of obesity in patients with renal cell carcinoma |
Abstract
PDF (Rus)
|
I. B. Kravtsov, V. A. Solodky, A. Yu. Pavlov, A. G. Dzidzaria, S. V. Fastovets, I. V. Khoroshevskaya |
|
Vol 19, No 1 (2023) |
Retroperitoneoscopic access in organ-preserving treatment of renal cell carcinoma |
Abstract
PDF (Rus)
|
V. S. Chaykov, I. O. Dementyev, O. B. Karyakin, E. O. Shchukina, A. V. Troyanov, S. A. Ivanov, A. D. Kaprin |
|
Vol 19, No 1 (2023) |
Efficacy and safety of cabozantinib in metastatic renal cell carcinoma patients: Russian multicenter observational study |
Abstract
PDF (Rus)
|
M. I. Volkova, A. S. Kalpinskiy, K. V. Men'shikov, L. V. Gorbuleva, O. I. Evsyukova, V. R. Meltonyan, S. V. Mishugin, M. R. Maturov, A. S. Ol'shanskaya, D. Yu. Shemetov, T. A. Sannikova, M. V. Makhnutina, M. A. Filip'eva, E. A. Gaysina, E. G. Ovchinnikova, V. B. Matveev, B. Ya. Alekseev |
|
Vol 19, No 1 (2023) |
Robot-assisted repeat resection of recurrent kidney tumors |
Abstract
PDF (Rus)
|
B. G. Guliev |
|
Vol 19, No 1 (2023) |
Review of the article “Retroperitoneoscopic access in organ-preserving treatment of renal cell carcinoma” |
Abstract
PDF (Rus)
|
D. V. Perlin |
|
Vol 18, No 4 (2022) |
Results of surgical treatment of malignant kidney tumors based on the materials of urology departments of the Siberian State Medical University clinics |
Abstract
PDF (Rus)
|
V. R. Latypov, V. S. Popov, V. N. Latypova, S. I. Novikov, D. B. Akhmedov, O. S. Zebzeeva |
|
Vol 18, No 4 (2022) |
Study of the action of peripheral blood T-lymphocytes on renal cell carcinoma cells in model systems |
Abstract
PDF (Rus)
|
A. Yu. Kuzevanova, O. A. Khalmurzaev, A. A. Borunova, N. V. Apanovich, T. N. Zabotina, A. A. Alimov, V. B. Matveev, A. V. Karpukhin |
|
Vol 18, No 3 (2022) |
New lenvatinib and pembrolizumab combination for metastatic renal cell carcinoma in 1st line drug treatment: comparative effectiveness and safety |
Abstract
PDF (Rus)
|
B. Ya. Alekseev, I. M. Shevchuk |
|
Vol 18, No 3 (2022) |
Evaluation of quality of life of patients with solitary renal cancer metastases in bones before and after surgical treatment in combination with targeted therapy and without it |
Abstract
PDF (Rus)
|
S. V. Kostritskiy, V. I. Shirokorad, B. Ya. Alekseev, D. V. Semenov, A. S. Kalpinskiy, Yu. S. Korneva |
|
Vol 18, No 3 (2022) |
Preventive sutures in nonischemic laparoscopic partial nephrectomy. Description of S.P. Botkin City Clinical Hospital technique |
Abstract
PDF (Rus)
|
A. A. Seregin, A. V. Seregin, K. B. Kolontarev, I. V. Seregin, A. I. Makhmadaliev, O. B. Loran |
|
Vol 18, No 3 (2022) |
Transperitoneal laparoscopic and robot-assisted resection of anterior and posterior kidney tumors |
Abstract
PDF (Rus)
|
B. G. Guliev, B. K. Komyakov, Kh. Kh. Yakubov |
|
Vol 18, No 3 (2022) |
Review of the article “Transperitoneal laparoscopic and robot-assisted resection of anterior and posterior kidney tumors” |
Abstract
PDF (Rus)
|
D. V. Perlin |
|
Vol 18, No 3 (2022) |
Techniques of surgical hemostasis and sealing after laparoscopic partial nephrectomy |
Abstract
PDF (Rus)
|
A. K. Nosov, E. M. Mamizhev, N. A. Shchekuteev, D. P. Semeyko, P. A. Lushina, D. I. Rumyantseva, M. V. Berkut |
|
Vol 18, No 2 (2022) |
Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study |
Abstract
PDF (Rus)
|
R. Motzer, C. Porta, B. Alekseev, S. Y. Rha, T. K. Choueiri, M. J. Mendez-Vidal, S. H. Hong, A. Kapoor, J. C. Goh, M. Eto, L. Bennett, J. Wang, J. J. Pan, T. L. Saretsky, R. F. Perini, C. S. He, K. Mody, D. Cella |
|
Vol 18, No 2 (2022) |
Situation with cancer care in Russia. Kidney cancer (median survival, cumulative survival, and survival of patients depending on their disease stage). Population-based study at the federal district level. Part 2 |
Abstract
PDF (Rus)
|
V. M. Merabishvili, A. K. Nosov |
|
Vol 18, No 2 (2022) |
Prognostic significance of sPD-1/sPD-L1 in renal cancer depending on the phenotype of tumor and stromal cells |
Abstract
PDF (Rus)
|
O. V. Kovaleva, A. N. Gratchev, E. I. Makarova, S. D. Bezhanova, I. S. Stilidi, V. B. Matveev, N. E. Kushlinskii |
|
Vol 18, No 1 (2022) |
Review of the article “Laparoscopic partial nephrectomy: results of various surgery techniques” |
Abstract
PDF (Rus)
|
D. V. Perlin |
|
Vol 18, No 1 (2022) |
Laparoscopic partial nephrectomy: results of various surgery techniques |
Abstract
PDF (Rus)
|
V. K. Osetnik, R. V. Orlova, N. K. Gadzhiev, I. B. Dzhalilov, V. A. Rybalchenko, D. D. Shkarupa, I. V. Semenyakin, I. N. Kuzmina |
|
Vol 18, No 1 (2022) |
Laparoscopic radical nephrectomy with inferior vena cava level I–III thrombectomy: experience of one center and literature review |
Abstract
PDF (Rus)
|
A. K. Nosov, E. M. Mamizhev, B. I. Aslanov, R. I. Ryabinin, Kh. N. Bayramov, D. I. Rumyantseva, M. V. Berkut, D. V. Nekrasov |
|
Vol 17, No 4 (2021) |
Comparison of perioperative and short-term functional outcomes of laparoscopic partial nephrectomy in patients with cT1aN0M0 and cT1b-T2aN0M0 tumors |
Abstract
PDF (Rus)
|
S. V. Kotov, A. A. Nemenov, A. G. Yusufov, R. I. Guspanov, S. A. Pulbere, A. O. Prostomolotov |
|
Vol 17, No 4 (2021) |
Long-term oncological results of surgical treatment of localized renal tumors |
Abstract
PDF (Rus)
|
S. A. Rakul, K. V. Pozdnyakov, R. A. Eloev |
|
Vol 17, No 4 (2021) |
Assessment of the state and relationship of vasopressor and renin-angiotensin systems in patients with localized kidney cancer on the background of arterial hypertension |
Abstract
PDF (Rus)
|
R. A. Osokin, I. A. Aboyan, N. V. Soldatkina, E. F. Komarova, A. Yu. Maksimov, S. N. Vlasov |
|
Vol 17, No 4 (2021) |
Similarities and differences in the process of metastasis and differentiation of renal cancer on gene expression |
Abstract
PDF (Rus)
|
N. V. Apanovich, A. V. Matveev, P. V. Apanovich, A. A. Korotaeva, F. M. Kipkeeva, T. A. Muzaffarova, O. A. Khalmurzaev, V. B. Matveev, A. V. Karpukhin |
|
Vol 17, No 4 (2021) |
Quality-adjusted time without symptoms or toxicity (Q-TWiST) for lenvatinib plus everolimus versus everolimus monotherapy in patients with advanced renal cell carcinoma |
Abstract
PDF (Rus)
|
C. H. Lee, Y. Wan, A. Smith, R. Xie, R. J. Motzer |
|
Vol 17, No 3 (2021) |
Experience of using 1st line combination immunotherapy in patients with metastatic renal cell carcinoma |
Abstract
PDF (Rus)
|
A. S. Kalpinskiy, I. V. Myslevtsev, A. N. Andrianov, K. M. Nyushko, M. P. Golovashchenko, N. V. Vorobiev, Ya. L. Chertkova, I. Kh. Shirukova, E. Yu. Usanova, B. Ya. Alekseev |
|
Vol 17, No 3 (2021) |
First experience of superselective embolization of renal arteries supplying the tumor with subsequent laparoscopic kidney resection |
Abstract
PDF (Rus)
|
V. L. Astashov, V. V. Shapovalov, V. V. Balanyuk, A. I. Zagorul’ho, D. V. Kozlov, M. A. Andreeva, O. R. Sinitsyna, A. S. Radomskiy |
|
Vol 17, No 3 (2021) |
Review of the article "Prognosis of patients operated on for renal cell carcinoma and tumor venous thrombosis: experience of the Urology Clinics, N.N. Blokhin National Medical Research Center of Oncology" |
Abstract
PDF (Rus)
|
P. A. Karnaukh |
|
Vol 17, No 3 (2021) |
Review of the article "First experience of superselective embolization of renal arteries supplying the tumor with subsequent laparoscopic kidney resection" |
Abstract
PDF (Rus)
|
D. V. Perlin |
|
Vol 17, No 3 (2021) |
Prognosis of patients operated on for renal cell carcinoma and tumor venous thrombosis: experience of the Urology Clinics, N.N. Blokhin National Medical Research Center of Oncology |
Abstract
PDF (Rus)
|
M. I. Volkova, N. L. Vashakmadze, A. V. Klimov, A. K. Begaliev, K. P. Kuznetsov, V. B. Matveev |
|
Vol 17, No 3 (2021) |
Long-term treatment outcomes of patients with non-clear cell renal cell carcinoma |
Abstract
PDF (Rus)
|
A. A. Mukhomedyarova, B. Ya. Alekseev, A. S. Kalpinskiy |
|
Vol 17, No 2 (2021) |
Complications of robot-assisted and laparoscopic partial nephrectomy |
Abstract
PDF (Rus)
|
S. A. Rakul, K. V. Pozdnyakov, R. A. Eloev |
|
Vol 17, No 2 (2021) |
Review of the article “Technique and short-term outcomes of surgical treatment in patients with renal cell carcinoma and tumor venous thrombosis: experience of the Urology Clinic, N.N. Blokhin National Medical Research Center of Oncology” |
Abstract
PDF (Rus)
|
П. А. Карнаух |
|
Vol 17, No 2 (2021) |
Technique and short-term outcomes of surgical treatment in patients with renal cell carcinoma and tumor venous thrombosis: experience of the Urology Clinic, N.N. Blokhin National Medical Research Center of Oncology |
Abstract
PDF (Rus)
|
V. B. Matveev, M. I. Volkova, N. L. Vashakmadze, I. S. Stilidi |
|
Vol 17, No 1 (2021) |
Nephrectomy and thrombectomy in renal cell carcinoma patients with extensive tumor venous thrombosis: how to minimize surgical risks? |
Abstract
PDF (Rus)
|
V. B. Matveev, I. S. Stilidi, M. I. Volkova, N. L. Vashakmadze, A. V. Klimov, A. K. Begaliev, P. I. Feoktistov, K. P. Kuznetsov, M. I. Davydov |
|
Vol 17, No 1 (2021) |
Efficacy and safety of lenvatinib and everolimus combination in patients with metastatic renal cell carcinoma progression following targeted antiangiogenic therapy: secondary analysis of data obtained in the Russian multicenter observational study |
Abstract
PDF (Rus)
|
M. I. Volkova, A. S. Kalpinskiy, P. S. Borisov, O. I. Evsyukova, A. S. Olshanskaya, V. B. Matveev, B. Ya. Alekseev, E. V. Peganova, A. F. Nasretdinov, E. V. Lymar, E. G. Ovchinnikova, T. A. Sveklina, E. A. Usynin, A. M. Abdelgafur, E. A. Tararova, L. M. Shumova, A. S. Belenkov, I. Yu. Dolgov, N. G. Ponomareva, I. V. Evstigneeva, A. N. Ivanov, A. R. Isaev, R. V. Leonenkov, A. V. Meskikh, M. R. Mukhitova, S. A. Orlova, I. V. Teslenok, M. M. Shegurova, M. T. Aivazov, Z. V. Amoev, K. G. Babina, A. A. Vorontsova, E. V. Karabina, N. V. Kirdakova, I. E. Shumskaya, G. P. Kolesnikov, E. S. Kuzmina, D. Kh. Latipova, E. S. Lyutova, M. M. Fael, A. N Chugarova, A. S. Antipin |
|
Vol 16, No 4 (2020) |
Clinical implication of kidney injury molecule (KIM-1) in blood plasma of renal-cell cancer patients |
Abstract
PDF (Rus)
|
E. S. Gershtein, D. S. Naberezhnov, A. A. Alferov, Svetlana D. Bezhanova, N. F. Frolova, V. B. Matveev, N. E. Kuslinskii |
|
Vol 16, No 4 (2020) |
Review of the article “Clinical implication of kidney injury molecule (KIM-1) in blood plasma of renal-cell cancer patients” |
Abstract
PDF (Rus)
|
A. Z. Vinarov |
|
Vol 16, No 4 (2020) |
Review of the article “Resection of a kidney tumor with superselective targeted balloon-occluded chemoembolization” |
Abstract
PDF (Rus)
|
A. M. Popov |
|
Vol 16, No 4 (2020) |
Рекомендации по лечению пациентов с прогрессирующим или метастатическим почечно-клеточным раком комбинацией ленватиниба и эверолимуса |
Abstract
PDF (Rus)
|
E. Grande, H. Glen, J. Aller, G. Argenziano, M. J. Lamas, P. Ruszniewski, J. L. Zamorano, K. Edmonds, S. Sarker, M. Staehler, J. Larkin |
|
Vol 16, No 4 (2020) |
Resection of a kidney tumor with superselective targeted balloon-occluded chemoembolization |
Abstract
PDF (Rus)
|
A. V. Maksimov, A. G. Martov, P. A. Neustroev, V. A. Alekseev, D. V. Peretolchin, L. A. Klarov, E. I. Neustroev, N. P. Kladkin |
|
Vol 16, No 4 (2020) |
The R.E.N.A.L. nephrometry score in radiologist’s practice |
Abstract
PDF (Rus)
|
N. A. Rubtsova, E. V. Kryaneva, A. B. Golbits, B. Ya. Alekseev, A. A. Kostin, А. D. Kaprin |
|
Vol 16, No 4 (2020) |
Methylation of a group of microRNA genes: markers of renal cell carcinoma metastasis |
Abstract
PDF (Rus)
|
N. V. Apanovich, V. I. Loginov, E. A. Filippova, D. S. Khodyrev, A. M. Burdennyy, I. V. Pronina, N. A. Ivanova, S. S. Lukina, T. P. Kazubskaya, V. B. Matveev, A. V. Karpukhin, E. A. Braga |
|
Vol 16, No 3 (2020) |
Combination of pembrolizumab and axitinib: a new gold standard in the first-line therapy for metastatic clear-cell renal-cell carcinoma? |
Abstract
PDF (Rus)
|
R. A. Gafanov, A. G. Dzidzaria, I. B. Kravtsov, S. V. Fastovets |
|
Vol 16, No 3 (2020) |
Combination of nivolumab and ipilimumab in the treatment of disseminated renal cell carcinoma. Realities and prospects |
Abstract
PDF (Rus)
|
B. Ya. Alekseev, I. M. Shevchuk |
|
Vol 16, No 3 (2020) |
The efficacy of lenvatinib plus everolimus in patients with metastatic renal cell carcinoma exhibiting primary resistance to front-line targeted therapy or immunotherapy |
Abstract
PDF (Rus)
|
L. Hamieh, R. L. Beck, V. H. Le, J. J. Hsieh |
|
Vol 16, No 3 (2020) |
KIM-1 (kidney injury molecule 1) in the urine of renal cell carcinoma patients |
Abstract
PDF (Rus)
|
K. Yu. Kanukoev, N. S. Sergeeva, T. A. Karmakova, N. V. Marshutina, M. P. Solokhina, K. M. Nyushko, B. Ya. Alekseev, A. D. Kaprin |
|
Vol 16, No 2 (2020) |
Laparoscopic thulium fiber laser partial nephrectomy without thermal ischemia |
Abstract
PDF (Rus)
|
V. N. Dubrovin, A. V. Egoshin, A. V. Tabakov, R. R. Shakirov, O. V. Mihaylovskiy |
|
Vol 16, No 2 (2020) |
Immunosuppressive peculiarities of stromal cells of various kidney tumor types |
Abstract
PDF (Rus)
|
O. V. Kovaleva, M. A. Rashidova, D. V. Samoilova, P. A. Podlesnaya, R. M. Tabiev, N. V. Kuntsevich, G. D. Efremov, B. Ya. Alekseev, A. N. Gratchev |
|
Vol 16, No 2 (2020) |
Normotension — new approach in laparoscopic partial nephrectomy |
Abstract
PDF (Rus)
|
I. B. Dzhalilov, V. K. Osetnik, E. M. Mamizhev, E. V. Parshina, S. S. Krestyaninov, M. A. Alekseev, R. V. Orlova |
|
Vol 16, No 2 (2020) |
Review of the article “Normotension — new approach in laparoscopic partial nephrectomy” |
Abstract
PDF (Rus)
|
D. V. Perlin |
|
Vol 16, No 2 (2020) |
Comparative clinical and economic analysis of using cabozantinib as second-line therapy for adult patients with advanced renal cell carcinoma |
Abstract
PDF (Rus)
|
I. S. Krysanov, V. S. Krysanova, B. Ya. Alekseev, V. Yu. Ermakova, E. V. Gameeva |
|
Vol 16, No 1 (2020) |
Expression of growth factors and tyrosine kinase receptors in the primary tumor and tumor thrombus cells in patients with renal cell carcinoma |
Abstract
PDF (Rus)
|
M. I. Volkova, A. S. Olshanskaya, I. V. Tsimafeyeu, N. L. Vashakmadze, Yu. A. Khochenkova, E. Sh. Solomko, S. A. Ashuba, D. A. Khochenkov, V. B. Matveev |
|
Vol 16, No 1 (2020) |
Tissue synthesis of some components of the renin-angiotensin system in hypertensive patients with localized kidney cancer |
Abstract
PDF (Rus)
|
R. A. Osokin, I. A. Aboyan, E. F. Komarova, A. Yu. Maksimov, E. Yu. Komarova |
|
Vol 16, No 1 (2020) |
Influence of surgical approach on enhanced recovery after surgery in laparoscopic radical nephrectomy |
Abstract
PDF (Rus)
|
D. V. Perlin, I. N. Dymkov, E. A. Davydova, A. O. Shmanev, A. V. Perlina |
|
Vol 15, No 4 (2019) |
Adrenal gland as a target of synchronous and metacronous metastasis from renal cell carcinoma: results of surgical treatment in a single institution |
Abstract
PDF (Rus)
|
A. G. Muradyan, A. A. Kostin, N. V. Vorobyev, A. O. Tolkachev |
|
Vol 15, No 4 (2019) |
Is technically complicated partial nephrectomy justified in renal cell carcinoma patients with normal contralateral kidney? |
Abstract
PDF (Rus)
|
M. I. Volkova, V. A. Ridin, V. A. Cherniayev, A. V. Klimov, K. M. Figurin, A. A. Kirichek, V. B. Matveev |
|
Vol 15, No 4 (2019) |
Pancreatic metastases from renal cancer: comparing surgery and pharmacotherapy efficacy |
Abstract
PDF (Rus)
|
A. G. Kotelnikov, A. G. Kriger, D. V. Podluzhny, I. S. Proskuryakov, G. V. Galkin, Yu. I. Patyutko, I. A. Fainstein |
|
Vol 15, No 4 (2019) |
Efficacy of incomplete metastasectomy in combination with targeted therapy in metastatic kidney cancer patients |
Abstract
PDF (Rus)
|
P. S. Borisov, R. V. Orlova, M. I. Shkolnik, P. A. Karlov, E. E. Topuzov |
|
Vol 15, No 3 (2019) |
Polymorphism of μ1-opioid receptor (OPRM1) gene may be of value in genesis of renal malignant neoplasm |
Abstract
PDF (Rus)
|
A. L. Potapov, A. D. Kaprin, S. A. Ivanov, A. V. Boiarkina, N. Yu. Novikov, R. R. Gevorkyan, I. P. Kostyuk |
|
Vol 15, No 3 (2019) |
Fast track for partial nephrectomy |
Abstract
PDF (Rus)
|
A. K. Nosov, S. B. Petrov, P. A. Lushina, M. V. Berkut, A. V. Semenov, A. E. Saad |
|
Vol 15, No 3 (2019) |
Review of the article “Polymorphism of μ1-opioid receptor (OPRM1) gene may be of value in genesis of renal malignant neoplasm” |
Abstract
PDF (Rus)
|
A. V. Karpukhin |
|
Vol 15, No 3 (2019) |
Efficacy and safety of lenvatinib in combination with everolimus in metastatic renal cell carcinoma resistant to antiangiogenic targeted therapy: Russian multicenter observational study ROSLERCM |
Abstract
PDF (Rus)
|
M. I. Volkova, A. M. Abdelgafur, M. T. Aivazov, Z. V. Amoev, K. G. Babina, P. S. Borisov, A. A. Vorontsovа, I. V. Evstigneeva, O. I. Evsyukova, O. V. Zhelezin, A. S. Kalpinsky, E. V. Karabina, N. V. Kirdakova, G. P. Kolesnikov, E. S. Kuzmina, D. Kh. Latipova, R. V. Leonenkov, M. R. Maturov, A. V. Meskikh, S. V. Mishugin, E. G. Ovchinnikova, A. S. Olshanskaya, S. A. Protsenko, T. Yu. Semiglazova, R. V. Smirnov, E. A. Usynin, M. M. Fael, E. M. Cherniakova, I. E. Shumskaya |
|
Vol 15, No 2 (2019) |
Evaluation of quality of life of patients after surgical treatment of kidney cancer |
Abstract
PDF (Rus)
|
S. V. Popov, R. G. Guseynov, I. N. Orlov, O. N. Skryabin, A. V. Davydov, R. S. Barkhitdinov, A. S. Katunin, M/ M. Mirzabekov |
|
Vol 15, No 2 (2019) |
Capabilities of preoperative targeted therapy in treatment of bone metastases in renal cancer |
Abstract
PDF (Rus)
|
Z. A. Yurmazov, N. A. Lushnikova, L. V. Spirina, E. A. Usynin, E. M. Slonimskaya, I. I. Anisenya, A. V. Bogoutdinova |
|
Vol 15, No 1 (2019) |
Kidney cancer mortality in Primorsky Krai |
Abstract
PDF (Rus)
|
L. F. Pisareva, G. N. Alekseeva, N. P. Lyakhova, A. К. Doroshenko, N. V. Cherdyntseva, E. L. Choynzonov |
|
Vol 15, No 1 (2019) |
Comparative analysis of short-term results of retroperitoneoscopic and laparoscopic radical nephrectomy for large kidney tumors |
Abstract
PDF (Rus)
|
Z. A. Kadyrov, A. Yu. Odilov, D. M. Yagudaev |
|
Vol 15, No 1 (2019) |
Review of the article “Laparoscopic management renal cell carcinoma in left kidney with tumor caval thrombus” |
Abstract
PDF (Rus)
|
B. G. Guliev |
|
Vol 15, No 1 (2019) |
Soluble forms of the immune check-point receptor PD-1 and its ligand PD-L1 in blood serum of patients with renal cell carcinoma: clinical and pathologic correlations |
Abstract
PDF (Rus)
|
N. E. Kushlinskii, E. S. Gershtein, I. O. Goryatcheva, A. A. Morozov, A. A. Alferov, S. D. Bezhanova, I. A. Kazantseva, V. V. Bazaev, V. B. Matveev |
|
Vol 15, No 1 (2019) |
Laparoscopic management renal cell carcinoma in left kidney with tumor caval thrombus |
Abstract
PDF (Rus)
|
D. V. Perlin, I. V. Alexandrov, I. N. Dymkov, A. O. Shmanev |
|
Vol 15, No 1 (2019) |
Prognostic role of PBRM1 marker expression in clear-cell renal-cell carcinoma |
Abstract
PDF (Rus)
|
D. G. Zaridze, N. N. Mazurenko, S. D. Bezhanova, D. M. Maksimovich, O. V. Shangina, V. A. Draudin-Krylenko, A. F. Mukeria, V. B. Matveev |
|
Vol 14, No 4 (2018) |
Renal cell carcinoma: What’s new in 2018 |
Abstract
PDF (Rus)
|
V. B. Matveev, A. S. Markova |
|
Vol 14, No 4 (2018) |
Therapeutic effects of pazopanib treatment in patients with metastatic kidney cancer in real clinical practice |
Abstract
PDF (Rus)
|
P. G. Berezin, V. V. Milovanov, A. A. Ivannikov, N. A. Ognerubov |
|
Vol 14, No 4 (2018) |
Comparative analysis of intra- and postoperative complications of retroperitoneoscopic and laparoscopic nephrectomy for large tumors |
Abstract
PDF (Rus)
|
Z. A. Kadyrov, A. Yu. Odilov, D. M. Yagudaev |
|
Vol 14, No 4 (2018) |
Safety of left renal vein ligation during circular resection of the inferior vena cava in right-side kidney carcinoma with tumor venous thrombosis |
Abstract
PDF (Rus)
|
M. I. Volkova, V. A. Chernyaev, A. K. Begaliev, A. V. Klimov, V. B. Matveev |
|
Vol 14, No 4 (2018) |
Review of the article “Comparative analysis of intra- and postoperative complications of retroperitoneoscopic and laparoscopic nephrectomy for large tumors” |
Abstract
PDF (Rus)
|
D. V. Perlin |
|
Vol 14, No 4 (2018) |
A joint determination of gene expression and methylation for the diagnosis of clear cell renal cancer |
Abstract
PDF (Rus)
|
N. V. Apanovich, V. I. Loginov, P. V. Apanovich, D. A. Sergeev, T. P. Kazubskaya, B. Sh. Kamolov, E. A. Braga, V. B. Matveev, A. V. Karpukhin |
|
Vol 14, No 3 (2018) |
PROGNOSTIC VALUE OF MATRIX METALLOPROTEINASE 9 IN RENAL CELL CARCINOMA |
Abstract
PDF (Rus)
|
T. M. Cherdantseva, I. P. Bobrov, S. V. Varlamov, M. N. Myadelets, I. V. Klimachev, A. M. Avdalyan, D. I. Ganov, A. F. Lazarev |
|
Vol 14, No 3 (2018) |
CURRENTLY AVAILABLE TREATMENT OPTIONS FOR METASTATIC RENAL CELL CARCINOMA |
Abstract
PDF (Rus)
|
B. Ya. Alekseev, A. D. Kaprin, G. P. Kolesnikov, A. A. Mukhomed’yarova, E. I. Konopleva, A. S. Kalpinskiy |
|
Vol 14, No 2 (2018) |
Modern approaches to kidney cancer immunotherapy |
Abstract
PDF (Rus)
|
N. E. Kushlinskii, M. V. Fridman, A. A. Morozov, E. S. Gershtein, Z. G. Kadagidze, V. B. Matveev |
|
Vol 14, No 2 (2018) |
Resection of the inferior vena cava in patients with renal cell carcinoma with bulky tumor venous thrombosis |
Abstract
PDF (Rus)
|
M. I. Davydov, V. B. Matveev, M. I. Volkova, K. M. Figurin, V. A. Chernyaev, A. M. Klimov, A. K. Begaliev, P. I. Feoktistov, K. P. Kuznetsov, I. V. Nekhaev, O. V. Zhuzhginova, E. V. Ogorodnikova, S. M. Mkhitaryan |
|
Vol 14, No 2 (2018) |
Review of the article “Prognostic factors of acute renal failure following partial nephrectomy of solitary kidney” |
Abstract
PDF (Rus)
|
|
|
Vol 14, No 2 (2018) |
Review of the article “Resection of the inferior vena cava in patients with renal cell carcinoma with bulky tumor venous thrombosis” |
Abstract
PDF (Rus)
|
|
|
Vol 14, No 2 (2018) |
Individual approach in choosing second-line targeted therapy for metastatic renal cell carcinoma |
Abstract
PDF (Rus)
|
B. Ya. Alekseev, I. M. Shevchuk, A. D. Kaprin |
|
1 - 100 of 251 Items |
1 2 3 > >>
|